Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 5, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT .
Toggle Summary AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 . Members of AbbVie's executive leadership team will present virtually at 2:45 p.m. CT , including Robert A.
Toggle Summary AbbVie to Present at the Evercore ISI Conference
NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 4 th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief
Toggle Summary AbbVie to Present at the Piper Sandler Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33 rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief
Toggle Summary AbbVie to Present at the Wolfe Research Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and
Toggle Summary AbbVie Reports Third-Quarter 2021 Financial Results
- Reports Third-Quarter Diluted EPS of $1.78 on a GAAP Basis, an Increase of 38.0 Percent; Adjusted Diluted EPS of $3.33, an Increase of 17.7 Percent - Delivers Third-Quarter Net Revenues of $14.342 Billion, an Increase of 11.2 Percent on a GAAP Basis; Adjusted Net Revenues Increased 11.3 Percent
Toggle Summary AbbVie to Host Third-Quarter 2021 Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 5, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2021 financial results on Friday, October 29, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 10, 2021 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.  The cash dividend is payable November 15, 2021 to stockholders of record at the close of business on October 15, 2021 .
Toggle Summary AbbVie to Present at the Morgan Stanley Healthcare Conference
NORTH CHICAGO, Ill. , Sept. 9, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on Wednesday, September 15, 2021 . Richard A. Gonzalez , chairman and chief executive officer, Michael Severino , M.D., vice chairman and
Toggle Summary AbbVie Reports Second-Quarter 2021 Financial Results
- Reports Second-Quarter Diluted EPS of $0.42 on a GAAP Basis; Adjusted Diluted EPS of $3.11 - Delivers Second-Quarter Net Revenues of $13.959 Billion, an Increase of 33.9 Percent on a Reported Basis - Second-Quarter Global Net Revenues from the Immunology Portfolio Were $6.120 Billion, an Increase